Ads
related to: biomarker
Search results
Annexon’s ANX005 offers improvement in Phase III GBS trial
Clinical Trials Arena via Yahoo Finance· 3 days agoIn addition, an early reduction in serum levels of neurofilament light chain, a biomarker of nerve...
Personalis CEO Chris Hall leads a cancer detecting trailblazer - San Francisco Business Times
The Business Journals· 2 days agoChris Hall was just another Midwestern guy lured to the magical electricity of the dot-com-era Bay...
Newswise Expert | Debora Bruno, Case Western Reserve University
Newswise· 2 days agoDr. Bruno is a medical oncologist and clinical researcher with a focus on lung cancer and other thoracic malignancies such as thymomas/thymic carcinomas as well as mesothelioma. As such, she ...
Can losing your sense of smell predict heart failure?
The Times of Northwest Indiana· 9 hours agoLosing the ability to smell properly – a common sensory deficit as people age – may help predict or even contribute to the development of heart failure, new research suggests.
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoMerus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today ...
Thrombectomy Less Beneficial in Large-Core Stroke
Medscape· 2 days agoA secondary analysis of the SELECT2 trial suggests that large-core ischemic stroke patients with the greatest volume of tissue injury may benefit less from thrombectomy.
Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study
Benzinga via Yahoo Finance· 4 days agoOn Tuesday, Annexon Inc (NASDAQ:ANNX) released topline results from its Phase 3 trial in patients...
Accessing Alzheimer's Disease care a long road for patients
The Center Square· 3 days agoWith an aging population, experts told the House Aging and Older Adults Services Committee that the need to address Alzheimer’s head-on is pressing. According to Dr. Oscar Lopez, director of ...
Quanterix keeps Hold rating, steady stock target on strategic advantages By Investing.com
Investing.com· 24 hours agoOn Friday, TD (TSX:TD) Cowen maintained its Hold rating on Quanterix Corp. (NASDAQ:QTRX) with a...
Agilent (A) Boosts Reach to Lab Researchers With New Devices
Zacks via Yahoo Finance· 2 days agoAgilent (A) boosts its presence in the mass spectrometry market with the launch of the Agilent 7010D...